Jonathan M. Brotchie

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Exosome markers of LRRK2 kinase inhibition”.

Exosome markers of LRRK2 kinase inhibition

npj Parkinson s Disease(2020)10.1038/s41531-020-00138-7

N/A

0DataRank · unranked

24 citations

Kaela Kelly, Jonathan M. Brotchie, James B. Koprich, Andrew B. West, Shijie Wang

A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease

Experimental Neurology(2020)10.1016/j.expneurol.2020.113514

N/A

0DataRank · unranked

29 citations

Courtney A. Marshall, Lauren Keibel, Nathaniel W. Snyder, Michael P. Hill, Jonathan M. Brotchie +4 more

Pharmacodynamic Markers of LRRK2 Inhibition in Biofluids

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.28.923557

N/A

0DataRank · unranked

1 citations

Kaela Kelly, Nathalie Schussler, Sylviane Boularand, Laurent Dubois, Frank Hsieh +5 more